Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structural features, including the fluorinated aryl group and constrained cyclobutane ring, make it valuable in medicinal chemistry for enhancing metabolic stability and binding affinity. Commonly employed in the preparation of protease inhibitors and receptor modulators. Also utilized in research settings to explore structure-activity relationships in drug candidates.